TITLE:
Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men

CONDITION:
Osteoporosis

INTERVENTION:
Zoledronic Acid

SUMMARY:

      The goal of this study is to determine the effectiveness and safety of an annual intravenous
      treatment of zoledronic acid for the treatment of osteoporosis in men. All patients will
      receive calcium and vitamin D supplements.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Male
Age: 25 Years to 85 Years
Criteria:

        Inclusion Criteria:

          -  Male, 25-85 years old

        Exclusion Criteria:

          -  Current users of bisphosphonates such as Aredia (pamidronate), Didronel
             (etidronate), Fosamax (alendronate), Actonel  (residronate), Skelid (tiludronate)

          -  History of severe liver, kidney or eye disease

        Other protocol-defined inclusion/exclusion criteria may apply.
      
